VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,617,500 | -59.9% | 50,000 | +4657.4% | 2.06% | -58.8% |
| Q1 2022 | $4,031,000 | +0.7% | 1,051 | -15.9% | 5.02% | +69.2% |
| Q4 2021 | $4,004,000 | -52.9% | 1,250 | -99.5% | 2.97% | -13.7% |
| Q2 2021 | $8,495,000 | +354.5% | 250,000 | +334.8% | 3.44% | +366.5% |
| Q1 2021 | $1,869,000 | -93.2% | 57,500 | +8114.3% | 0.74% | -95.7% |
| Q3 2020 | $27,412,000 | +453.2% | 700 | -99.5% | 17.18% | +203.2% |
| Q2 2020 | $4,955,000 | +109.8% | 135,100 | +31.8% | 5.67% | +25.0% |
| Q1 2020 | $2,362,000 | -22.0% | 102,500 | -1.0% | 4.53% | +144.6% |
| Q4 2019 | $3,030,000 | +310.6% | 103,500 | +195.7% | 1.85% | +173.3% |
| Q4 2018 | $738,000 | – | 35,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |